Single Dose Versus Five-day Course of Oral Ciprofloxacin as Prophylaxis After Manual Vacuum Aspiration for Incomplete Miscarriage In Gusau: A Randomized Controlled Trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202407476433553

Enrollment

128

Registered

2024-07-22

Start date

2023-07-10

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abortion

Interventions

Group A

Group B

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Women with incomplete miscarriage. 2. Women who consent for MVA for management of miscarriage and agree to participate in the study. 3. Women who agree to follow up visit in the hospital or at least telephone follow up for clients living far from the hospital.

Exclusion criteria

Exclusion criteria: 1. Allergy to fluoroquinolones. 2. Contraindications to fluoroquinolones (e.g., breastfeeding patients) 3. Clinical suspicion of infection. 4. Those who present with incomplete abortion after an unsafe abortion. 5. Those who are on antibiotic therapy or in the last one week for other reasons. 6. Immunosuppressive state 7. Patients not able to take orally

Design outcomes

Primary

Measure	Time frame
Post abortion sepsis	—

Secondary

Measure	Time frame
Side effects, Compliance with medications, duration of bleeding.	—

Countries

Nigeria

Contacts

Public ContactOlaniyi Fasanu

Senior registrar Federal Medical Centre Gusau

nfashtolu@yahoo.com+2347035353990

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026